Limaprost-d3 Catalog No.:M26610-C The blocking Bcr-Abl kinase activity

The blocking Bcr-Abl kinase activity using PD180970 in the human K562 CML cell line resulted in inhibition of Stat5 DNA-binding activity with an IC50 of 5 nM

3S)-2-[[(2S)-2-[[(2S)-2-[[(2S

Phase I clinical trials of palovarotene in patients with emphysema demonstrated that the drug is well tolerated

LY367385 shows greater efficacy than LY367366 and neither of these compounds influenced neuronal viability per se

Enhancement of proteasome activity through inhibition of Usp14 may offer a strategy to reduce the levels of aberrant proteins in cells under proteotoxic stress

Limaprost-d3 Catalog No.:M26610-C The blocking Bcr-Abl kinase activityLimaprost d3 (17,20 dimethyl 2 PGE1 d3) is the deuterium labeled Limaprost. Limaprost (OP1206) is a PGE1 analogue and a potent and orally active vasodilator. Limaprost increases blood flow and inhibits platelet aggregation. Limaprost pain relief, has antianginal effects, and can be used for ischaemic symptoms research. Product information CAS Number: 1263190 37 9 Molecular Weight: 383. 54 Formula: C22H36O5 Chemical Name: (2E) 7 [(1R,2R,3R) 3 hydroxy 2